In this video, John M. Kane III, MD, FACS, chair of Surgical Oncology and Chief of the Melanoma/Sarcoma Service at Roswell Park, discusses some of the unique aspects of surgical oncology offered at the center and recent innovations in techniques
Wednesday, February 16th, 2022 | 5:00 - 6:30 PM EST
The same biochemical triggers that spur a “fight or flight” response when we encounter threats may help tumor cells to thrive.
Shalana O'Brien, MD, is a highly skilled surgical oncologist treating patients with melanoma/skin cancers, endocrine disorders and cancers, and specializing in heated chemotherapy (HIPEC) to treat advanced cancers that have spread within the abdomen.
Although most primary cutaneous melanomas are treated with surgical excision alone, current international guidelines vary on the optimal size for the surgical margins, which can range from 1 to 3 cm. based on Breslow thickness.
A central question in oncology is how to offer efficacious treatments while minimizing toxicity. This is especially true when treating advanced sarcoma and melanoma of the extremity.
New findings could lead to better tools for the identification of at-risk individuals, earlier cancer prevention.
JAMA Oncology provides new insights that survival benefits are held regardless of BRAF mutation status or earlier targeted therapy.
This site is intended for healthcare professionals